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A community resource for paired genomic and 
metabolomic data mining
Genomics and metabolomics are widely used to explore specialized metabolite diversity. The Paired Omics Data 
Platform is a community initiative to systematically document links between metabolome and (meta)genome data, 
aiding identification of natural product biosynthetic origins and metabolite structures.
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Interactions between bacteria, fungi, plants, and animals, as well as their environments are often facilitated 
through specialized metabolites, also known 
as natural products. These specialized 
metabolites are molecules naturally 
produced by organisms that are not strictly 
required for survival but may confer an 
advantage to the producing organism, 
such as the inhibition of nearby species 
competing for nutritional resources. The 
chemical structures and functions, as 
well as the biosynthetic origins of such 
metabolites, are largely hidden, especially 
in complex environments. To understand 
and harness these chemical interactions, it is 
crucial to study their genetic and structural 
bases. However, the confident recognition, 
dereplication, and prioritization of 
specialized metabolites in complex mixtures 
remains very challenging. While individual 
efforts to interpret the chemical and genetic 
languages have been largely successful 
in connecting genes and molecules1,2, 
large-scale correlations leveraging 
complementary chemical and genomic data 
have yet to be realized.
The research community has generated 
a wealth of genomic and metabolomic data, 
which has been deposited in dedicated 
repositories, and tools for mining these 
data separately are being developed 
rapidly. Platforms such as the antibiotics 
and Secondary Metabolite Analysis Shell 
(antiSMASH)3 and PRediction Informatics 
for Secondary Metabolomes (PRISM)4 
use genomic information to annotate 
biosynthetic gene clusters (BGCs), a set of 
genes that encode the producing framework 
for metabolites of diverse chemical classes, 
such as polyketides, peptides and terpenoids. 
The antiSMASH database and the Joint 
Genome Institute’s (JGI’s) Integrated 
Microbial Genomes and Microbiomes 
(IMG/M)/Atlas of Biosynthetic Gene 
Clusters (IMG/ABC) database5 contain tens 
of thousands of BGCs identified in publically 
available genomes, while the Minimum 
Information about a Biosynthetic Gene 
cluster (MIBiG)6 database connects over 
2,000 BGCs to the specialized metabolites 
for which they encode the biosynthetic 
pathways. On the metabolomics side, mass 
spectrometry (MS) has become the most 
commonly used technique for performing 
high-throughput measurements2. Data 
repositories and analysis platforms such 
as the Global Natural Product Social 
Molecular Networking-Mass Spectrometry 
Interactive Virtual Environment 
(GNPS-MassIVE)7, MetaboLights8, and 
the Metabolomics Workbench9 facilitate 
the sharing, processing, and analysis of MS 
data. These platforms, along with spectral 
libraries2, such as the GNPS spectral library, 
METLIN, MassBank, and the commercially 
available NIST library, provide resources 
for reference mass spectra of a wide range 
of chemical structures, thereby aiding 
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metabolite annotation. Together, these 
resources provide the basis for sharing and 
reusing genomic and metabolomic data and 
structural annotations and have spurred the 
development of numerous algorithms for 
mining these information-dense data.
Several studies and tools have started 
to explore the combination of genomic 
and metabolomic data to enhance 
metabolite annotation, dereplication, and 
prioritization workflows. While MS-based 
metabolomics provides increasing amounts 
of information related to the metabolite 
structures present in complex mixtures, it 
faces inherent limitations with respect to 
structural identification. To address this, 
several tools, such as GNPS-based molecular 
networking7 and mass spectrometry to 
latent dirichlet allocation (MS2LDA) 
substructure discovery10, have been 
proposed that computationally exploit 
tandem mass spectrometry (MS/MS) 
fragmentation spectra to map relationships 
between metabolites in networks and 
identify (shared) substructures, thereby 
facilitating metabolite annotation. 
Genomics has also been used to provide 
complementary structural information 
through the biotransformations encoded 
in biosynthetic machinery1, as well as 
a way to link specialized metabolites to 
their producers via BGCs that are mined 
from genome sequences from known 
organisms. Integrative strategies have been 
described for bacterial11, fungal12, and 
plant13 specialized metabolites. A series 
of tools and approaches, mostly targeting 
biosynthetically modular natural products 
such as peptides and glycosides, have 
been introduced over the last decade to 
integrate genome and metabolome data, 
such as peptidogenomics11, MetaMiner14, 
GRAPE-GARLIC15 and metabologenomics16. 
These tools show the potential of combined 
omics approaches to accelerate natural 
product discovery.
It has become standard procedure to 
deposit genomic information to public 
databases, such as the National Center 
for Biotechnology Information’s (NCBI’s) 
GenBank17 or JGI’s IMG/M5, and it is 
becoming increasingly common to submit 
mass spectrometry data to repositories 
such as GNPS-MassIVE7, MetaboLights8 
or Metabolomics workbench9. However, 
there is currently no straightforward way to 
connect different types of omics data that 
are derived from the same biological source. 
It often takes extensive literature review 
to determine which omics data belong to 
the same species, organism, or sample, 
and therefore constitute ‘paired’ datasets, 
making reuse of these data challenging and 
time consuming. Additionally, there is no 
straightforward way to obtain consistent 
metadata for such links. To facilitate 
large-scale, effective integration of these 
data, it is vital to have a community-driven 
online resource that stores annotated links 
between paired datasets. Here, we refer to 
paired data as genomic data (specifically 
a genome or metagenome assembly) and 
metabolomic data (specifically MS/MS 
data) that originate from the same source. 
So far, no such platform supporting natural 
product discovery has been available. 
The value of integrating different data 
types and organizing sample metadata is 
increasingly recognized by the scientific 
community. For example, the BioStudies18 
and BioSample19 databases facilitate 
the capture and organization of various 
omics data types and sample information. 
In particular, the BioStudies database 
supports linkage between genomics and 
metabolomics studies; however, links 
between genome-mining resources, such as 
MIBiG, and natural product metabolomics 
platforms, such as GNPS-MassIVE, are 
currently not documented in this database.
Here we introduce the Paired Omics 
Data Platform (PoDP) to streamline 
access to paired omics data so that both 
humans and computers can access and 
read paired datasets and can also record 
and exploit validated links between BGCs 
and metabolites (https://pairedomicsdata.
bioinformatics.nl/). In addition to linking 
these omics data types, the platform stores 
essential metadata (i.e., growth media, 
extraction solvent, and ionization mode) 
using existing ontology where available, thus 
facilitating reuse of for-the-user relevant 
sections of paired data. This platform 
will boost the successful integration of 
unsupervised data-mining strategies to 
fine-tune the structural annotation of 
modular natural product classes and include 
yet-unknown classes of natural products. 
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Fig. 1 | overview of the Paired omics Data Platform. The PoDP links genomic and metabolomic 
data deposited in public repositories, accompanied by minimal metadata. The platform documents 
basic submitter information as well as accession numbers of the metabolome and genome data. 
Standardized logging of key experimental details enables users to better search and compare datasets, 
and user-defined labels of genome and experimental details (sections 3 and 4) enable straightforward 
submission of multiple links. The core of the platform consists of links between the genomic and 
metabolomic datasets and links between BGCs and MS/MS spectra, which facilitate data integration. 
PMID, PubMed ID; OD, optical density; CE, collision energy; SMILES, simplified molecular-input 
line-entry; IUPAC, International Union of Pure and Applied Chemistry; MS2, MS/MS fragmentation.
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annotations of natural products and the 
genes responsible for their production, and 
we anticipate that this will help uncover 
the potential producers of molecules in 
nature. Finally, registering these links in a 
standardized way gives the community an 
invaluable resource of Findable, Accessible, 
Interoperable, and Reusable (FAIR)20 data.
Standards for paired data
The aim of the PoDP is to connect public 
metabolomics datasets to their genomic 
origins. The PoDP does not store any 
metabolomics or genomics datasets, but 
captures metadata defining pairs of omics 
datasets in existing public databases and 
platforms already validated and utilized 
by the genomics and metabolomics 
communities. The PoDP consists of a 
six-section form for easy and quick input 
of data (Fig. 1). The metadata is organized 
in projects that can consist of multiple 
related experiments, identified by their 
MassIVE accession or MetaboLights study 
identifier. The (meta)genomes(s) used in 
these experiments can all be added to the 
same project via a public database identifier 
(e.g., a NCBI GenBank accession number 
or JGI Genome ID), with the user creating 
easy-to-recall genome labels for each 
(meta)genome. Minimal metadata with 
information about sample preparation and 
data collection are recorded in a modular 
way, allowing for multiple experimental 
set-ups within one project. Furthermore, 
through BioSample accession IDs, metadata 
stored elsewhere can be linked to (meta)
genome(s) as well. User-specified metadata 
labels are also used for easy recall in the 
linking step, in which a URL for a specific 
set of MS spectra is linked with the 
genome label and metadata labels to create 
a genome–metabolome link. To create a 
BGC–MS/MS link, a MIBiG identifier for 
the same or similar BGC can be linked with 
a MS/MS URL and scan number of a single 
measured molecule or molecular network 
nodes (representing unique measured 
molecules) in a molecular family (a group 
of structurally related molecules identified 
by similar fragmentation patterns). This 
approach thus stimulates the submission 
of validated gene clusters to the MIBiG 
repository in order to make a BGC–MS/MS 
link in the PoDP.
By obtaining iterative feedback from a 
group of early users from various research 
groups, we narrowed down the required 
metadata in the PoDP to the minimum 
information needed to make meaningful 
links between genomic and metabolomic 
data relevant to the community. Capturing 
the full range of relevant variables in any 
given experiment in a standardized and 
machine-readable format would lead to 
a very complex and tedious data entry 
process. Therefore, a balance was struck 
between flexible and user-friendly data 
entry, maintaining machine readability 
for future large-scale analyses. By 
standardizing and connecting to ontologies 
only the most relevant information that 
could substantially affect the metabolites 
produced, extracted, and detected by MS, 
we arrived at a set of minimal metadata 
required for submission.
To enable machine readability of the 
data, ontologies are used to standardize 
response options wherever possible. This 
ensures that a global community can 
use the same term for a given piece of 
metadata and use these ontologies to make 
accurate and meaningful selections of data 
to analyze. For example, researchers can 
reliably select and obtain only datasets that 
use tryptic soy broth for culture or only 
metagenomic datasets derived from aquatic 
invertebrates, or just the fraction of paired 
datasets in which the MS data was obtained 
in positive ionization mode. For metadata 
categories with numerous options, in which 
all possibilities cannot be captured by 
standard ontologies, an “Other” category is 
provided for further explanation. Free text 
entered in the “Other” boxes is inherently 
not machine-readable but gives an option 
for customization by the user and can help 
to keep important but non-standardized 
records of the paired data. Furthermore, 
all fields including the “Other” boxes can 
be searched to find projects containing 
specific data.
Box 1 | Preliminary submissions to the PoDP
Early contributors to the PoDP seeded the platform with 70 projects 
from over 45 labs in 10 countries. These 70 projects encompass: 
• 1,268 genomes
• 1,306 metagenomes
• 42 metagenome-assembled genomes  
• 4,853 paired (meta)genomes and metabolomes 
• 114 validated links between BGCs and MS/MS spectra 
• 155 sample growth conditions
• 100 extraction methods
• 75 instrumentation methods
Because all data linked in the platform must already be in a public database, 
many early contributors made data public that had previously not been public. 
Some early contributors went a step further and actually acquired genomic or 
metabolomic data to complement already public data and make paired datasets.
Submitting genomic and metabolomic data to the PoDP will increase visibility 
of those data and allow researchers to adhere to FAIR data principles.  




An initial call to deposit paired datasets 
in the PoDP was met with enthusiasm 
from the research community. Over 
45 laboratories from 10 countries have 
contributed 70 paired datasets. Those 
70 projects (Box 1) contain 4,853 MS 
samples associated with sequenced source 
material. Of the more than 2,600 different 
genomic sources deposited, 1,306 are 
metagenomes, 1,268 are genomes, and 
42 are metagenome-assembled genomes. 
The impressive collection of over 4,800 
genome–metabolome links is accompanied 
by metadata: 155 sample preparation 
methods, 100 extraction methods, and 75 
instrumentation methods. Furthermore, 
114 links between BGCs and their 
associated MS/MS spectra are registered 
in the platform. These community-curated 
data are regularly archived to a Zenodo 
dataset and made available for download in 
JSON format.
The PoDP encourages adherence to FAIR 
principles20, requiring data to already be 
deposited in databases and made publicly 
available before being entered in the PoDP. 
Presence of a project in the PoDP will increase 
the findability of those data, results, and 
publications, while allowing researchers to 
perform new analyses on existing publicly 
available data without the need to generate 
new data. As part of this community effort, 
a number of projects deposited in the PoDP 
made their data publicly available to allow 
submission into the platform; thus far, over 
680 metabolomics samples and over 70 
genomic sources, including five BGCs newly 
uploaded to MIBiG, were made public. For 
example, the PoDP stimulated the upload 
of metabolomics data to MassIVE for a 
collection of 120 sequenced Streptomyces 
strains for which genomics data was 
previously published21. In another example, 
20 metagenomes from marine sediments were 
made public for the platform. Additionally, 
some datasets were acquired and made 
publicly available expressly for deposition into 
the PoDP. In one case, a research group with 
44 already sequenced cyanobacterial strains22 
was inspired to acquire metabolomics data for 
each strain so that the paired data could be 
uploaded to the PoDP.
To better view the data encompassed 
by the PoDP, users can search for projects 
under the “List” tab, using keywords to 
find studies of interest. For example, 
to find paired data resulting from a 
Streptomyces or Salinispora species, 
searching for the genera (“Streptomyces 
| Salinispora”) will result in the projects 
(currently 18) that measured Streptomyces 
or Salinispora strains. Likewise, to compare 
projects that used methanol to extract 
cell pellets, searching “methanol + cells” 
retrieves projects that used methanol 
to extract cell pellets. To obtain more 
detail on the metadata contained in each 
project, users can navigate to the project 
page by clicking on the project identifier. 
There, users can find details about the 
genome or metagenome when clicking on 
the label, which will then provide a link 
to the publically available genomic data. 
Likewise, the publically available MS data 
can be downloaded directly from the link 
provided. Clicking on the Sample Growth, 
Extraction, and Instrumentation Methods 
labels will display the corresponding 
metadata.
applications of the platform
The PoDP can be used in both basic and 
advanced ways. In a basic way, researchers 
from across disciplines can apply linked  
data for numerous applications (Fig. 2).  
With linked data, we refer to a BGC that  
can be experimentally linked to a MS/MS  
spectrum or a molecular family. For 
example, a natural product chemist who 
isolates a molecule from a cyanobacterium 
can use the PoDP to find mass spectra 
from genetically similar cyanobacteria 
for comparative metabolomics analyses. 
A biologist who has identified a BGC of 
interest and has MS data for the producing 
strain can download data for the products 
of similar BGCs and their products to 
determine whether the BGC is novel  
and/or to guide molecule isolation.  
Scientists from all fields can find 
reliable paired data for use in their own 
research while also contributing their 
data for future community use. The 
importance of consistent metadata cannot 
be underestimated, and we welcome 
the development of curated resources 
such as the Natural Products Atlas23 
that aim to create coherent records for 
microbial natural products. Combined 
with the PoDP, this gives researchers 
complementary resources to mine for 
natural product structures, their producers, 
and available omics data.
Furthermore, more advanced 
applications are possible utilizing large- 
scale computational approaches (Fig. 2).  
Several algorithmic strategies to link 
genomics and metabolomics data to chart 
specialized metabolic diversity have been 
suggested, including correlation- and 
feature-based matching2. Both types of 
linking benefit from systematically  
curated datasets of related organisms with 
BGCs and metabolites occurring in various 
samples. With the PoDP in place now,  
these strategies can be used more  
effectively to select appropriate datasets 
to start mining for novel links. Moreover, 
algorithms to score and rank links  
between BGCs and metabolites are easier  
to develop and benchmark: for example, 
a new set of scores was recently proposed 
using a number of PoDP datasets with 
validated BGC–metabolite links to 
demonstrate the effect of the novel scoring 
system within the newly introduced 
NPLinker framework24.
I  am studying a strain or environment:
• Find metabolomics data for related strains or environments
• Locate genomic data for related strains or environments 
I identified an interesting BGC:
• Locate metabolomics data for a similar BGC
• Find other validated BGCs from similar sources 
I isolated a natural product:
• Find out if other strains that produce this molecule share BGCs with my strain
• Determine if this molecule is already linked with a BGC 
I want to use big data to find new connections:
• Gather validated paired datasets to train a model
• Test computational hypotheses with paired data 
Fig. 2 | example use cases of the Paired omics Data Platform. Users may approach the PoDP using 
genomic or metabolomic data (or using metadata) and exploit the links provided to generate new 
hypotheses about their primary data. Specifically, genomic data may enable new hypotheses about the 
structures or biosynthetic pathways for an identified molecule or mass feature, while metabolomic data 
may provide new hypotheses regarding the product(s) of a BGC. Integrative computational approaches 
allow scaling these analyses to systematic and comprehensive efforts.
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moving forward with Fair data
The amount of preliminary data deposited 
and the enthusiasm from the community 
for the PoDP reaffirm the need for such 
a repository of paired public datasets. 
Feedback from early users also indicated 
an eagerness to include additional kinds 
of data in the future. Presently, the PoDP 
is expressly for linking MS/MS data and 
whole-genome or metagenome data. 
Potentially, the PoDP could be developed to 
include other types of spectral data, like full 
scan (MS1) metabolomics mass spectrometry 
data and NMR, as well as proteomics data. 
Additionally, different kinds of genomic data 
could be facilitated, including 16S rRNA or 
other amplicon sequences, transcriptomic 
data, and genetic manipulation or 
heterologous expression data. Such additions 
will further fuel integrated omics analysis 
tools and approaches, a field that has gained 
much traction recently25.
The PoDP requires researchers to 
deposit their data in public databases, 
stimulating the upload of data by early 
users, which is exemplified by more than 
1,800 GNPS-MassIVE and MetaboLights 
submissions just prior to submitting these 
data in the PoDP. As a FAIR data platform, 
the PoDP not only facilitates reuse of data, 
but also promotes the work of researchers 
who submit their data to the PoDP, through 
increased publication visibility. Future efforts 
to (re)use these data by connecting to other 
platforms and programs for analyzing paired 
data, such as NPLinker24, will further the field 
of natural product prediction and discovery.
Reporting Summary. Further information 
on research design is available in the Nature 
Research Reporting Summary linked to  
this article.
Data availability
Each project can be downloaded from the 
website individually as a JSON file. The 
(meta)genome and metabolome datasets 
can be found in their public repositories. 
All PoDP projects are archived monthly 
to Zenodo at https://doi.org/10.5281/
zenodo.3736430.
Code availability
The software is licensed under the Apache 
2.0 open source license and the source code 
can be found on GitHub (https://github.
com/iomega/paired-data-form), which 
includes the dependencies of the software. 
Each software release is archived to  
Zenodo at https://doi.org/10.5281/
zenodo.2656630. A full description of how 
the platform was built can be found on 
https://pairedomicsdata.bioinformatics. 
nl/methods. ❐
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